UPDATE 1-Samsung biopharma unit mulling NASDAQ listing to raise about $1.34 bln By: Reuters: Company News June 28, 2015 at 20:33 PM EDT * Samsung Bioepis seen worth 8 trln won market cap-media (Adds Cheil-C&T merger significance, shareholding) Read More >>